FDA Panel Votes to Recommend Most Serious Warnings on ADHD Medicines

WASHINGTON (AP) -- A federal advisory committee is recommending a so-called "black box" warning for stimulants prescribed for attention deficit hyperactivity disorder.

The Food and Drug Administration Committee voted eight-to-seven with one abstention to recommend the most serious type of warning on the labels of Ritalin and other A-D-H-D drugs. Doctors prescribe the increasingly popular drugs to about two (m) million children and one (m) million adults a month.

The F-D-A isn't required to follow the recommendations but typically does.

The vote followed a unanimous recommendation that the F-D-A require that the drugs include a medication guide. It comes on the heels of reports that 25 people using the drugs had died.

Doctor Kate Gelperin of the Food and Drug Administration says a possible link between the drugs and cardiovascular problems is not conclusive.